Articles

  • Oct 30, 2024 | msn.com | Polly Toynbee |Frances Ryan |Jon Moulton |Sahil Dutta |Sharon Graham |John Redwood

    Continue reading More for You

  • Apr 10, 2024 | penews.com | Jon Moulton

    I was reading the recently published and excellent Bain Global Private Equity Report. They somewhat bemoaned the adverse effects of interest rate rises that followed on from higher inflation and now see the coming of lower interest rates as good news for leveraged buyouts. Should they not be hoping for more inflation?

  • Feb 13, 2024 | penews.com | Jon Moulton

    Net Asset Loans: are they clever or too clever? I’m talking about loans made secured against the net assets of a fund (Net Asset Value loans). For those who remember the Global Financial Crisis, if you substitute “NAV loans” for “sub-prime housing” then much that happened in sub-prime lending could happen in the world of NAV loans. NAV comes in a wide variety of structures.

  • Jan 22, 2024 | penews.com | Jon Moulton

    A few weeks ago the government published The Independent Review of University Spin-Out Companies. Its oddest feature is its title. The review was initiated by the government and staffed, it seems, exclusively by people who are not independent. Vice chancellors, other industry academic investors and the like. Excellent and talented they hopefully all are – but independent they are not. As a group, the thing they are most likely to agree on is increasing the size of the cake. The...

  • Nov 14, 2023 | penews.com | Jon Moulton

    Numis have just done a poll of mid-market private equity firms in the UK. It shows some very interesting results. The compulsion felt by the need to do deals is illustrated by the odd fact that 53% of PE managers felt that private assets are more overvalued than public assets whereas their appetite for buying public assets has fallen drastically from 73% in 2022 to 14% today.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →